RBC Capital Markets upgraded biotechnology company Gilead to its top pick from outperform and maintained its $91 price target.
A scientist at Gilead Sciences analyzes patient antibody levels at the Gilead laboratory in Foster City, Calif.stock as the company begins to stabilize, while still trading at a discount to its peers, according to RBC Capital Markets.
The firm named biotechnology company Gilead to its top picks list and maintained its $91 price target, a near 34% upside.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
The Queen's Top Secret Security Code Name Is Sharon, ApparentlyA royal aide revealed that Queen Elizabeth's code name with security is Sharon.
Weiterlesen »
Before biting into that burger: Is fake meat better for you, or the environment?Based on calories alone, plant-based protein is healthier than animal-based meat. But there's much more to the story.
Weiterlesen »
China September exports, imports in deeper contraction as tariffs take tollA slide in China's exports picked up pace in September while imports contra...
Weiterlesen »
College football player surprises stepdad with last name change'You know how much I love you, right? And how I always treasure the time I have with you? Now you're my world; I got my last name changed.'
Weiterlesen »
Beta Nordic Studios Launches With Fisher King Joint VentureJan Mojto’s Munich-based production and distribution company Beta Film has taken a majority stake in Finnish production company Fisher King, and has launched Sweden-based Beta Nordic Studios, which…
Weiterlesen »